Taxotere Approved for Use to Treat Type of Prostate Cancer
May 2004 – Taxotere was approved for use in combination with prednisone for the treatment of metastatic, androgen-independent prostate cancer. Reference: Martins, Ines. “Docetaxel.” Prostate Cancer News Today, 11 Mar. 2016, prostatecancernewstoday.com/docetaxel/
Continue Reading